Over the past 25 years, medical protocols have been developed that reduce the occurrence of OHSS in patients undergoing COS, such as administering a GnRH agonist trigger rather than a trigger containing hCG. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.